Chandan Healthcare Reports 19.6% Revenue Growth; Pivots to Diagnostic-Led Strategy
Chandan Healthcare Limited (CHANDAN) reports Q1 FY27 revenue growth of 19.62% to ₹82.26 Cr. Discover how the firm is pivoting to a high-margin diagnostic model.
ALFA News
Straight from the exchange filing
Quarterly results and earnings calls from NSE- and BSE-listed companies.
Chandan Healthcare Limited (CHANDAN) reports Q1 FY27 revenue growth of 19.62% to ₹82.26 Cr. Discover how the firm is pivoting to a high-margin diagnostic model.
Alpex Solar Limited reports Q1 FY27 revenue of 503.42 Cr. Management targets 4,000 Cr revenue by FY28 driven by its new 2.2GW TopCon cell manufacturing line.
Z-Tech (India) reports a 51.55% YoY revenue jump to ₹31.19 Cr in Q1 FY27. Learn about the strategic pivot to the Zyng annuity platform and ₹300 Cr order book.
One Point One Solutions reports 129% YoY revenue growth in Q1 FY27 following the Netcom acquisition. Management aims to double revenue via AI-driven models.
Suraj Industries reports Q1FY27 net income of ₹30 crore, up 282% YoY, as it pivots to a fully integrated Alco-Bev model with a ₹450 crore FY27 revenue target.
Finkurve Financial Services (FINKURVE) reports 135% AUM growth and 88% revenue jump in Q1 FY27. Management guides for 50-60% growth as branch network scales.
BEML reports its strongest Q1 in a decade with 29% revenue growth and ₹16,000 Cr order book. Management eyes ₹40,000 Cr bidding pipeline for future expansion.
GK Energy reports record Q1 FY27 revenue of ₹505 Cr, up 71.1% YoY. Management maintains guidance to double revenue for the full year on strong solar pump demand.
Network People Services Technologies (NPST) posts 75% YoY revenue growth to ₹61.4 Cr in Q1 FY27, maintaining a ₹900 Cr revenue target for FY29 despite QoQ dip.
Max India Ltd reports a 66% YoY revenue jump to ₹68.6 Cr in Q1 FY27. Antara Noida handovers and senior care occupancy drive growth despite EBITDA losses.
Kwality Pharmaceuticals revises FY27 revenue target to ₹700Cr+ and eyes ₹1,500Cr by FY30. Highlights include biosimilar expansion and 26-27% EBITDA margins.
Thomas Scott (India) Limited recorded a 63% YoY revenue jump in Q4 FY26. Management targets 60% growth in FY27 driven by premium international brand licensing.
Jyoti Resins & Adhesives Ltd reported Q1 FY27 revenue of ₹877.1 Mn, up 17% YoY. Management targets EBITDA margin recovery to 23-25% in Q2 after RM cost spikes.
Sejal Glass Ltd reported 52.88% YoY revenue growth in Q1 FY27. Management raised annual guidance to 40% and announced AED 15M capex for UAE expansion.
Corona Remedies Ltd (CORONA) reported ₹422.43 Cr revenue for Q1 FY27, up 21.9% YoY. Management highlights 30.1% PAT growth and new hormonal facility commissioning.
Alembic Pharmaceuticals reports 26% YoY revenue growth to INR 2,150 Cr in Q1 FY27, driven by US Generics. Management raises full-year growth guidance to mid-teens.
Kwality Pharmaceuticals reports 45.7% YoY revenue growth in Q1FY27 to ₹162.4 Cr. Management raises FY27 revenue guidance to ₹700+ Cr on strong export demand.
Sky Gold and Diamonds reports Q1FY27 revenue of ₹2,012.8 Cr, up 77.9% YoY. The company raises FY27 revenue guidance to ₹8,100 Cr under its Sky Gold 3.0 strategy.
Rushil Decor reports Q1 FY2027 revenue of ₹2,290 million, up 27.8% YoY. Laminate sales surged 65.3% while Jumbo Laminates achieved a high 20.6% EBITDA margin.
Sri Lotus Developers reports Q1 FY27 revenue growth of 116% to ₹132 crore. Pre-sales surged 567% to ₹409 crore with a debt-free, net cash balance sheet.